Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Presented for research literature review only Eckert R et al
By consolidating mechanistic insight, clinical validation, safety profiling, pharmacokinetic challenges, and translational strategies into a unified model, this manuscript aims to provide an evidence-based and clinically actionable framework that extends beyond prior narrative summaries
After 2448 h, the cells were incubated with the TRaQ-G ligand for 1 h
112 Animal studies have shown that suppressing the activity of MG53 and SOCS1 improves insulin sensitivity and protects against metabolic dysfunction
Wu Q, Fu S, Xiao H, Du J, Cheng F, Wan S, et al
US$ 22.67
US$ 25.84
US$ 25.02
